NIOX Group (NIOX) Share Price, News & Analysis

Company Overview

NIOX Group Plc engages in the design, development, and commercialization of medical devices for the measurement of fractional exhaled nitric oxide (FeNo) worldwide. Its products include NIOX VERO, a non-invasive and point-of-care system that comprises a small portable device and a range of consumables, including sensors, individual disposable mouthpieces, and breathing handles for the measurement of FeNo level in patients. The company was formerly known as Circassia Group Plc and changed its name to NIOX Group Plc in September 2022. NIOX Group Plc was incorporated in 2006 and is headquartered in Oxford, the United Kingdom.

Key Stats

• Today's Range: 63.20 to 65
• 50-Day Range: 55.90 to 76.04
• 52-Week Range: 53.40 to 80
• Volume: 336,699 shs
• Average Volume: 1.35 million shs
• Market Capitalization: £26.13 billion
• P/E Ratio: 2,625.94
• Dividend Yield: 1.57%
• Price Target: GBX 90
• Consensus Rating: Buy

NIOX Group Stock Analysis - MarketRank™

NIOX Group scored higher than 40% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.5 / 5
• Analyst Rating: Buy

Consensus Rating

NIOX Group has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings.

Amount of Analyst Coverage

NIOX Group has only been the subject of 2 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.0 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of NIOX Group is 2,674.18, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 24.81.

Price to Earnings Ratio vs. Sector

The P/E ratio of NIOX Group is 2,674.18, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 26.73.

Price to Book Value per Share Ratio

NIOX Group has a P/B Ratio of 3.59. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: N/A
• Short Interest Level: N/A

Short Interest

There is no current short interest data available for NIOX.

Dividend

• Score: 0.8 / 5
• Dividend Strength: Weak

Dividend Yield

NIOX Group pays a meaningful dividend of 1.66%, higher than the bottom 25% of all stocks that pay dividends.

Dividend Growth

NIOX Group does not have a long track record of dividend growth.

Dividend Coverage

The dividend payout ratio of NIOX Group is 4,126.83%. Payout ratios above 75% are not desirable because they may not be sustainable.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Short Interest

There is no current short interest data available for NIOX.

News and Social Media

• Score: 0.7 / 5
• News Sentiment: -0.66

News Sentiment

NIOX Group has a news sentiment score of -0.66. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.69 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 4 news articles for NIOX Group this week, compared to 1 article on an average week.

Company Ownership

• Score: 3.3 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, NIOX Group insiders have sold 42,423.78% more of their company's stock than they have bought. Specifically, they have bought £10,196.32 in company stock and sold £4,335,860.75 in company stock.

Percentage Held by Insiders

46.72% of the stock of NIOX Group is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

Only 35.23% of the stock of NIOX Group is held by institutions.

NIOX Stock Analysis - Frequently Asked Questions

How have NIOX shares performed this year?

NIOX Group's stock was trading at GBX 63 at the start of the year. Since then, NIOX shares have increased by 2.9% and is now trading at GBX 64.80.
View the best growth stocks for 2025 here.

How were NIOX Group's earnings last quarter?

NIOX Group Plc (LON:NIOX) released its earnings results on Tuesday, April, 1st. The company reported $2.27 EPS for the quarter. NIOX Group had a net margin of 28.21% and a trailing twelve-month return on equity of 13.29%.

How do I buy shares of NIOX Group?

Shares of NIOX stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What other stocks do shareholders of NIOX Group own?

Based on aggregate information from My MarketBeat watchlists, some other companies that NIOX Group investors own include Petrofac (PFC), MICT (MICT), Chemring Group (CHG) and N Brown Group (BWNG).

Company Calendar

• Last Earnings: 4/01/2025
• Today: 5/23/2025

Industry, Sector and Symbol

• Stock Exchange: LON
• Sector: Medical
• Industry: Medical Devices
• Sub-Industry: N/A
• Current Symbol: LON:NIOX
• CIK: N/A
• Web: investors.niox.com
• Phone: 44 18 6540 5560
• Fax: N/A
• Employees: 92
• Year Founded: N/A

Price Target and Rating

• Average Stock Price Target: GBX 90
• High Stock Price Target: GBX 90
• Low Stock Price Target: GBX 90
• Potential Upside/Downside: +43.3%
• Consensus Rating: Buy
• Rating Score (0-4): 3.00
• Research Coverage: 2 Analysts

Profitability

• EPS (Most Recent Fiscal Year): GBX 0.02
• Trailing P/E Ratio: 2,591.65
• Forward P/E Ratio: 53.87
• P/E Growth: N/A
• Net Income: £995.88 million
• Net Margins: 28.21%
• Pretax Margin: N/A
• Return on Equity: 13.29%
• Return on Assets: 3.95%

Debt

• Debt-to-Equity Ratio: 1.10
• Current Ratio: 6.31
• Quick Ratio: 1.94

Sales & Book Value

• Annual Sales: £3.53 billion
• Price / Sales: 7.31
• Cash Flow: GBX 5.60 per share
• Price / Cash Flow: 11.21
• Book Value: GBX 18.03 per share
• Price / Book: 3.48

Miscellaneous

• Outstanding Shares: 41,071,615,003
• Free Float: N/A
• Market Cap: £25.79 billion
• Optionable: Not Optionable
• Beta: 0.92